Haoxin Appoints Two New Independent Directors, Gets Nasdaq Bid Price Extension to Dec 14
HXHX sits 54% above its 52-week low of $0.325.
Summary
Haoxin Holdings appointed Rohit Phansalkar and Mengzhi Wang as independent directors, filling vacancies from resignations effective July 8. Phansalkar, a veteran investment banker, chairs the Compensation Committee; Wang chairs the Audit Committee. The company also disclosed a Nasdaq extension to December 14 to regain $1 minimum bid compliance, warning of a potential reverse split. This follows a June 30 financing deal and a July 24 SEC filing that first noted the director replacements and extension. The new directors bring financial and governance expertise, but the looming delisting risk and tiny $6.9M market cap keep the outlook uncertain.
At the time of this announcement, HXHX was trading at $0.50 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $6.9M. The 52-week trading range was $0.32 to $1.84. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.